Dissecting the Abuse Liability of Synthetic Cathinone Stimulants
Dissecting the Abuse Liability of Synthetic Cathinone Stimulants
批准号:
9161060
负责人:
TOBIN J DICKERSON
金额:
$43.31万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2021-06-30
关键词:
AffectAmericasAmphetaminesBathingBrainCarbonCharacteristicsCocaineDependenceDrug AddictionEnvironmentExhibitsGeographic stateGoalsHealthHumanIntakeIntravenousInvestigationLegalMarketingMedical emergencyMethamphetamineModelingParentsPersonal SatisfactionPharmaceutical PreparationsPopulationPropertyPsychological reinforcementPsychotropic DrugsRattusReinforcement ScheduleReportingRiskRodentRodent ModelSaltsScheduleSelf AdministrationSiblingsSpeedStructureTailTestingUnited StatesWorkaddictioncathinonecollegedesigndrug efficacydrug modificationecstasyin vivolipophilicitymeetingsmonomethylpropionneurochemistrypsychostimulantreinforcersymposium
中文摘要
合成精神活性卡西酮药物(“浴盐”)的使用在全世界继续扩大
英文摘要
The use of synthetic psychoactive cathinone drugs (“bathsalts”) continues to expand worldwide
and in the United States of America despite legal control efforts internationally, at the US federal
level, within multiple US states and even the local US jurisdictions. The established stimulants such
as cocaine and methamphetamine are highly addictive, can be acutely lethal and can result in long-
term brain alterations with many implications for health and well-being. Recent studies show that 3,4-
methylenedioxypyrovalerone (MDPV) is a highly potent and efficacious reinforcer, predicting abuse
liability equal to or greater than that of cocaine and methamphetamine. Compounds such as
Mephedrone and Methylone produce subjective properties that are similar to 3,4-
methylenedioxymethamphetamine (MDMA) but have exhibit much greater propensity for compulsive
use in human report and rodent self-administration studies. This project responds to the goals of
PAR-14-106 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious
Effects by determining structural determinants of the addiction liability of synthetic cathinones.
Tremendous diversity of cathinone structure exists in the recreational market, driven in part by legal
control of earlier-appearing drugs. This reality demands approaches which can both advance
understanding of the actions of currently popular drugs and generate better predictions regarding
which design motifs may convey increased abuse liability in emerging compounds. To that end,
studies under Aim I and Aim II will elucidate the contributions of the 3,4-methylenedioxy and 4-
methyl aromatic ring substitutions, respectively, to the reinforcement potency and efficacy of
cathinones. One distinct feature of MDPV is an extended carbon chain which confers enhanced
lipophilicity. The goal of Aim III is to determine if stimulant drug efficacy in intravenous self-
administration is affected by lipophilicity, which affects speed of brain entry. In total, these proposed
studies on the reinforcing effects of various synthetic cathinones will advance our understanding of
the health risks associated with designer stimulant drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Real-Time Cellular Screening Systems for BoNT Intoxication
-
批准号:8761600
-
项目类别:
-
资助金额:$44.97万
-
财政年份:2014
-
负责人:TOBIN J DICKERSON
-
依托单位:
Development of Real-Time Cellular Screening Systems for BoNT Intoxication
-
批准号:8892063
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2014
-
负责人:TOBIN J DICKERSON
-
依托单位:
Development of Real-Time Cellular Screening Systems for BoNT Intoxication
-
批准号:9085209
-
项目类别:
-
资助金额:$45.86万
-
财政年份:2014
-
负责人:TOBIN J DICKERSON
-
依托单位:
Predicting Protein Evolution with Phage Escape
-
批准号:7707091
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
Small Molecule Therapeutics for Botullinum Neurotoxin A
-
批准号:8445323
-
项目类别:
-
资助金额:$110.19万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
Small Molecule Therapeutics for Botullinum Neurotoxin A
-
批准号:7797686
-
项目类别:
-
资助金额:$119.18万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
Predicting Protein Evolution with Phage Escape
-
批准号:7860354
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
Small Molecule Therapeutics for Botullinum Neurotoxin A
-
批准号:8242825
-
项目类别:
-
资助金额:$116.42万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
Small Molecule Therapeutics for Botullinum Neurotoxin A
-
批准号:7645253
-
项目类别:
-
资助金额:$123.67万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
Small Molecule Therapeutics for Botullinum Neurotoxin A
-
批准号:8052806
-
项目类别:
-
资助金额:$115.73万
-
财政年份:2009
-
负责人:TOBIN J DICKERSON
-
依托单位:
The Role of Nornicotine in protein Glycation
-
批准号:6663294
-
项目类别:
-
资助金额:$1.92万
-
财政年份:2002
-
负责人:TOBIN J DICKERSON
-
依托单位:
The Role of Nornicotine in protein Glycation
-
批准号:6584038
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2002
-
负责人:TOBIN J DICKERSON
-
依托单位:
海外基金